Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzoquinone SCHEMBL6026862 | 0.67 | ALDH1A1 (0.68) | MEN1ALDH1A1MAPTHPGDALOX12 | |
| SCHEMBL4911549 | 0.65 | MEN1 (0.47) | MEN1ALDH1A1MAPTHPGDALOX12 | |
| SCHEMBL8664716 | 0.64 | MEN1 (0.48) | MEN1ALDH1A1MAPTHPGDALOX12 | |
| SCHEMBL10786855 | 0.63 | MEN1 (0.42) | MEN1ALDH1A1MAPTHPGDALOX12 | |
| SCHEMBL48973 | 0.63 | TDP1 (0.42) | MEN1ALDH1A1MAPTHPGDALOX12 | |
| SCHEMBL9928465 | 0.63 | MEN1 (0.42) | MEN1ALDH1A1MAPTHPGDALOX12 | |
| SCHEMBL5160541 | 0.63 | MEN1 (0.42) | MEN1ALDH1A1MAPTHPGDALOX12 | |
| SCHEMBL21141253 | 0.63 | MEN1 (0.42) | MEN1ALDH1A1MAPTHPGDALOX12 | |
| SCHEMBL7186512 | 0.63 | MAPT (0.42) | MEN1ALDH1A1MAPTHPGDALOX12 | |
| SCHEMBL17033515 | 0.63 | MEN1 (0.42) | MEN1ALDH1A1MAPTHPGDALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1304924-A2 | COMPOSITIONS FOR REPELLING CRAWLING INSECTS | Bayer Aktiengesellschaft (DE) | 2003-05-02 | — | — | EP | disclosed |
| US-20020094993-A1 | Compositions for repelling crawling insects | S.C. JOHNSON & SON, INC. | 2002-07-18 | — | — | US | disclosed |
| WO-2002005646-A2 | COMPOSITIONS FOR REPELLING CRAWLING INSECTS | S.C. JOHNSON & SON, INC. (US) (US) | 2002-01-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020094993-A1 | Compositions for repelling crawling insects | ACHE, DDT, GAP43 | MEN1 3828/4885ALDH1A1 1488/4885MAPT 3240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.